Researchers at the University of California, San Diego, believe they have discovered the "root cause" of Type 2 diabetes — a molecular link between obesity and diabetes that may lead to new treatment.
LY293111 can be administered safely by continuous oral therapy with mild toxicities. Diarrhea is dose-limiting. The recommended phase II dose will be 600 mg BID. The steady-state concentrations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results